Hackensack Meridian - John Theurer Cancer Center — Edison, New Jersey

Hackensack Meridian - John Theurer Cancer Center is a clinical research site located in Edison, New Jersey, United States 08837.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Hackensack Meridian - John Theurer Cancer Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced Solid Tumor, Metastatic Solid Tumor, Head and Neck Squamous Cell Carcinoma.

Sponsors: InduPro, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Edison

Browse all research sites in New Jersey · View every site in Edison

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hackensack Meridian - John Theurer Cancer Center?

Hackensack Meridian - John Theurer Cancer Center has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hackensack Meridian - John Theurer Cancer Center conducted?

Hackensack Meridian - John Theurer Cancer Center has 1 clinical trials on record, with 1 currently active. Their work covers Advanced Solid Tumor, Metastatic Solid Tumor, Head and Neck Squamous Cell Carcinoma.

Is Hackensack Meridian - John Theurer Cancer Center accredited by Crixeo Clinical Trials?

Hackensack Meridian - John Theurer Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Hackensack Meridian - John Theurer Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.